Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Woman reading the article on multiparametric MRI in prostate cancer treatments on her laptop

Use of Multiparametric MRI in Prostate Cancer Treatments: A Prospective Study

The prospective study conducted by LMU Klinikum München investigates the effectiveness of vascular-targeted photodynamic therapy (VTP) and high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer.

Using multiparametric MRI (mpMRI), ten patients were monitored over the course of one year to track anatomical changes and potential tumor recurrence.

The results show that mpMRI reliably captures changes in prostate and tumor volumes, with an initial increase in prostate volume, followed by a significant reduction after one year. A recurrence was detected in one patient.

mpMRI proves to be a valuable tool for monitoring tumor recurrence, but further validation in larger studies is required.

Read more about the study here.

Related Resources

Related Resources

University Hospital Jena: Research Investigating the Viability of Accelerating Whole-Body MRI in Children and Adolescents through STIR DWI with Simultaneous Multi-Slice Excitation

This study[1] addressed the challenges of conducting WB-MRI in paediatric patients, particularly the prolonged acquisition time required for…

WUSTL: Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations

In this retrospective study utilizing the mint Lesion™ software[1], researchers found that routine clinical interpretations frequently resulted in the…

A screenshot of a structured report from mint Lesion™

Tumor Growth Rate Modeling: A Novel Approach to Evaluating the Efficacy of Cancer Therapies

The 2020 review of Clinical Trial Evidence Supporting US Food and Drug Administrative Approval of Novel Cancer Therapies Between 2000 and 2016…